Reply to Jakovac: About COVID-19 and vitamin D.
作者信息
Facchiano Angelo, Facchiano Antonio, Bartoli Manuela, Ricci Alberto, Facchiano Francesco
机构信息
National Research Council, CNR-ISA, Avellino, Italy.
Istituto Dermopatico dell'Immacolata, IDI-IRCCS Rome, Italy.
出版信息
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E838. doi: 10.1152/ajpendo.00185.2020.
Abstract
摘要
相似文献
1
Reply to Jakovac: About COVID-19 and vitamin D.对亚科瓦茨的回复：关于新冠病毒与维生素D
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E838. doi: 10.1152/ajpendo.00185.2020.
2
Reply to Jakovac: COVID-19, vitamin D, and type I interferon.对亚科瓦茨的回复：2019冠状病毒病、维生素D与I型干扰素
Am J Physiol Endocrinol Metab. 2020 Aug 1;319(2):E245-E246. doi: 10.1152/ajpendo.00315.2020.
3
Reply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective?对雅科瓦茨的回复：苯丙酮尿症患者感染新冠病毒的严重程度：维生素D状态具有保护作用吗？
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E890-E891. doi: 10.1152/ajpendo.00195.2020.
4
Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?对雅科瓦茨以及罗查等人的回复：维生素D能否预防或治疗新冠疾病？
Am J Physiol Endocrinol Metab. 2020 Aug 1;319(2):E455-E457. doi: 10.1152/ajpendo.00348.2020.
5
Reply to Jakovac: Sex differences in COVID-19 course and outcome: progesterone should not be neglected.回复雅科瓦茨：COVID-19病程和结局中的性别差异：不应忽视孕酮。
J Appl Physiol (1985). 2020 Nov 1;129(5):1009-1010. doi: 10.1152/japplphysiol.00835.2020.
6
Reply to: "Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: Vitamin D Deficiency and Outcome of COVID-19 Patients. 2020, , 2757".回复：“维生素 D 不足可能导致近十分之九的 COVID-19 死亡：是采取行动的时候了。评论：维生素 D 缺乏和 COVID-19 患者的结果。2020 年，，2757”。
Nutrients. 2020 Nov 27;12(12):3643. doi: 10.3390/nu12123643.
7
Vitamin D and Covid-19: A Note of Caution.维生素D与新冠病毒：一则警示
Ir Med J. 2020 May 7;113(5):82.
8
Covid-19, Cocooning and Vitamin D Intake Requirements.新型冠状病毒肺炎、隔离防护与维生素D摄入需求
Ir Med J. 2020 May 7;113(5):79.
9
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North-supports vitamin D as a factor determining severity. Authors' reply.社论：北纬 35 度以南国家 COVID-19 死亡率低——支持维生素 D 是决定严重程度的因素。作者的回复。
Aliment Pharmacol Ther. 2020 Jun;51(12):1438-1439. doi: 10.1111/apt.15796. Epub 2020 May 12.
10
Vitamin D: A Nutrient To Bring To Light During COVID-19.维生素D：新冠疫情期间值得关注的一种营养素。
Altern Ther Health Med. 2020 Aug;26(S2):46-48.
引用本文的文献
1
A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency.维生素 D 缺乏与 COVID-19 风险和严重程度增加相关的初步证据概述。
Front Public Health. 2020 Sep 10;8:513. doi: 10.3389/fpubh.2020.00513. eCollection 2020.
2
Repurposing existing drugs for COVID-19: an endocrinology perspective.重新利用现有药物治疗 COVID-19：内分泌学视角。
BMC Endocr Disord. 2020 Sep 29;20(1):149. doi: 10.1186/s12902-020-00626-0.
3
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns.2019冠状病毒病时代糖尿病的临床管理：实际问题、特点与关切
J Clin Med. 2020 Jul 18;9(7):2288. doi: 10.3390/jcm9072288.
本文引用的文献
1
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D.性别特异性 SARS-CoV-2 死亡率：激素调节 ACE2 表达、静脉血栓栓塞和维生素 D 缺乏症风险。
Int J Mol Sci. 2020 Apr 22;21(8):2948. doi: 10.3390/ijms21082948.
2
COVID-19 and vitamin D-Is there a link and an opportunity for intervention?新型冠状病毒肺炎与维生素D——二者存在关联及干预机会吗？
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E589. doi: 10.1152/ajpendo.00138.2020.
3
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病（COVID-19）轻至中度形式的临床特征：一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
4
[The COVID-19 pandemic and otolaryngology: What it comes down to?].[新冠疫情与耳鼻咽喉科：归根结底是什么情况？]
Laryngorhinootologie. 2020 May;99(5):287-291. doi: 10.1055/a-1095-2344. Epub 2020 Mar 26.
5
Targeting Vitamin D Deficiency to Limit Exacerbations in Respiratory Diseases: Utopia or Strategy With Potential?针对维生素 D 缺乏症以限制呼吸系统疾病恶化：是乌托邦还是有潜力的策略？
Calcif Tissue Int. 2020 Jan;106(1):76-87. doi: 10.1007/s00223-019-00591-4. Epub 2019 Jul 26.
6
Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society.目前欧洲和中东国家的维生素 D 状况以及预防维生素 D 缺乏的策略：欧洲钙化组织学会的立场声明。
Eur J Endocrinol. 2019 Apr;180(4):P23-P54. doi: 10.1530/EJE-18-0736.
7
Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease.血清25-羟维生素D3水平可能与新发帕金森病的嗅觉功能障碍有关。
J Clin Neurosci. 2018 Nov;57:131-135. doi: 10.1016/j.jocn.2018.08.003. Epub 2018 Aug 19.
8
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.帕金森相关风险综合征（PARS）研究中的维生素 D。
Mov Disord. 2017 Nov;32(11):1636-1640. doi: 10.1002/mds.27127. Epub 2017 Sep 14.
9
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data.补充维生素D预防急性呼吸道感染：个体参与者数据的系统评价和荟萃分析
BMJ. 2017 Feb 15;356:i6583. doi: 10.1136/bmj.i6583.
10
Bone involvement in males with Kallmann disease.卡尔曼病男性患者的骨骼受累情况。
Aging Clin Exp Res. 2015 Oct;27 Suppl 1:S31-6. doi: 10.1007/s40520-015-0421-5. Epub 2015 Jul 23.
Zotero 插件